Physician profile
Igor Kagan
NPI 1245674241
$25,345.48
in general payments reported to CMS, 2019-2025
10 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $901 · 2020: $3,161 · 2021: $2,950 · 2022: $1,550 · 2023: $1,047 · 2024: $4,697 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Travel and Lodging: $733 · Food and Beverage: $612 · Education: $39.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,400.00 |
| Travel and Lodging | $732.89 |
| Food and Beverage | $611.50 |
| Education | $39.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $24,321.02 | 2019-2025 | Lokelma |
| Vifor Pharma, INC. | $297.47 | 2019-2021 | |
| Opko Pharmaceuticals, LLC | $125.46 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2019 | |
| Fresenius USA Marketing, INC. | $121.24 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $115.19 | 2019 | |
| Dynavax Technologies Corporation | $114.44 | 2019 | |
| Baxter Healthcare | $84.98 | 2019 | |
| Glaxosmithkline, LLC. | $39.14 | 2023 | Jesduvroq |
| Travere Therapeutics, INC. | $1.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Kagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.